12 min listen
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
ratings:
Length:
8 minutes
Released:
Jul 26, 2017
Format:
Podcast episode
Description
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Jul 26, 2017
Format:
Podcast episode
Titles in the series (100)
The Lancet Oncology: August 11, 2008 by The Lancet Oncology in conversation with